Changing of the Guard
Now That JTO Has Come of Age, What’s Next?
Have We Forgotten That Radiation is an Effective Therapy for Lung Cancer?
Chronic Obstructive Pulmonary Disease and Risk of Lung Cancer
Evaluating Beliefs Associated with Late-Stage Lung Cancer Presentation in Minorities
Significance of Folate Receptor Alpha and Thymidylate Synthase Protein Expression in Patients with Non–Small-Cell Lung Cancer Treated with Pemetrexed
Development and Validation of a Plasma Biomarker Panel for Discerning Clinical Significance of Indeterminate Pulmonary Nodules
Prognostic Significance of Predominant Histologic Pattern and Nuclear Grade in Resected Adenocarcinoma of the Lung
Immunohistochemistry is a Reliable Screening Tool for Identification of ALK Rearrangement in Non–Small-Cell Lung Carcinoma and is Antibody Dependent
Validation of the IASLC/ATS/ERS Lung Adenocarcinoma Classification for Prognosis and Association with EGFR and KRAS Gene Mutations
Underuse of Radiotherapy in Lung Cancer Has Negative Consequences for Patients
The Effects of Increased Provision of Thoracic Surgical Specialists on the Variation in Lung Cancer Resection Rate in England
Survival After Segmentectomy and Wedge Resection in Stage I Non–Small-Cell Lung Cancer
A Randomized Phase II Study of Gemcitabine and Carboplatin with or without Cediranib as First-Line Therapy in Advanced Non–Small-Cell Lung Cancer
How Sensitive Are Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors for Squamous Cell Carcinoma of the Lung Harboring EGFR Gene–Sensitive Mutations?
Prospective Assessment of Continuation of Erlotinib or Gefitinib in Patients with Acquired Resistance to Erlotinib or Gefitinib Followed by the Addition of Pemetrexed
Phase II Study of Induction Cisplatin and Irinotecan Followed by Concurrent Carboplatin, Etoposide, and Thoracic Radiotherapy for Limited-Stage Small-Cell Lung Cancer, CALGB 30206
Compound EGFR Mutations and Response to EGFR Tyrosine Kinase Inhibitors
Lungs Don’t Forget
Intrapulmonary Teratoma Presenting with Trichoptysis
Surviving Respiratory Insufficiency with Intensive Care Support in a Pretreated, Extensively Metastasized Patient with an EML4-ALK Translocation
High-Dose Pemetrexed in Combination with High-Dose Crizotinib for the Treatment of Refractory CNS Metastases in ALK-Rearranged Non–Small-Cell Lung Cancer
EGFR Mutations in Squamous Cell Lung Cancer in Never-Smokers
On Lymph Node Trays in Lung Cancer Surgery
On Lymph Node Trays in Lung Cancer Surgery
Lymphovascular Invasion in Non–Small-Cell Lung Cancer
Adjuvant Therapy for Resected Non–Small-Cell Lung Cancer with Lymphovascular Invasion